7-tert-Butyl-6-(4-chloro-phenyl)-2-thioxo-2,3-dihydro-1H-pyrido[2,3-d]pyrimidin-4-one, a classic polymodal inhibitor of transient receptor potential vanilloid type 1 with a reduced liability for hyperthermia, is analgesic and ameliorates visceral hypersensitivity

The Journal of Pharmacology and Experimental Therapeutics
Mark S NashStuart Bevan

Abstract

The therapeutic potential of transient receptor potential vanilloid type 1 (TRPV1) antagonists for chronic pain has been recognized for more than a decade. However, preclinical and clinical data revealed that acute pharmacological blockade of TRPV1 perturbs thermoregulation, resulting in hyperthermia, which is a major hurdle for the clinical development of these drugs. Here, we describe the properties of 7-tert-butyl-6-(4-chloro-phenyl)-2-thioxo-2,3-dihydro-1H-pyrido[2,3-d]pyrimidin-4-one (BCTP), a TRPV1 antagonist with excellent analgesic properties that does not induce significant hyperthermia in rodents at doses providing maximal analgesia. BCTP is a classic polymodal inhibitor of TRPV1, blocking activation of the human channel by capsaicin and low pH with IC(50) values of 65.4 and 26.4 nM, respectively. Similar activity was observed with rat TRPV1, and the inhibition by BCTP was competitive and reversible. BCTP also blocked heat-induced activation of TRPV1. In rats, the inhibition of capsaicin-induced mechanical hyperalgesia was observed with a D(50) value of 2 mg/kg p.o. BCTP also reversed visceral hypersensitivity and somatic inflammatory pain, and using a model of neuropathic pain in TRPV1 null mice we confirmed that its...Continue Reading

References

Jul 1, 1994·Gastroenterology·E A Mayer, G F Gebhart
May 24, 2000·Proceedings of the National Academy of Sciences of the United States of America·S W HwangU Oh
Jun 9, 2000·Annual Review of Neuroscience·J S MogilA I Basbaum
Feb 28, 2001·British Journal of Pharmacology·P McIntyreI F James
Feb 9, 2002·Brain Research. Molecular Brain Research·Tamas SzaboPeter M Blumberg
Jul 12, 2003·Pain·Asbjørn Mohr DrewesLars Arendt-Nielsen
Feb 7, 2004·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·D R RobinsonG A Hicks
Mar 31, 2004·British Journal of Pharmacology·Pierangelo Geppetti, Marcello Trevisani
Jul 13, 2004·Gut·B SchmidtH F Hammer
Nov 25, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·R Carter W JonesG F Gebhart
Sep 16, 2006·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Michael J Caterina
Feb 7, 2007·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·F AzpirozR C Spiller
Mar 23, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·David A AnderssonStuart Bevan
Mar 30, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Narender R GavvaJean-Claude Louis
Apr 28, 2007·Nature Reviews. Drug Discovery·Arpad SzallasiSamer R Eid
Jul 13, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Alexandre A SteinerAndrej A Romanovsky
Jul 27, 2007·The Journal of Pharmacology and Experimental Therapeutics·Narender R GavvaJames J S Treanor
Sep 23, 2008·Trends in Pharmacological Sciences·Narender R Gavva
Nov 11, 2008·Current Topics in Medicinal Chemistry·Lisa M BroadMaria-Jesus Blanco
Dec 10, 2008·Drug Discovery Today·Martin J Gunthorpe, Boris A Chizh
Jan 22, 2009·Pain·Charles H Knowles, Qasim Aziz
Mar 12, 2009·Current Pharmaceutical Design·Manojit PalNidhi Dhingra
Apr 4, 2009·Physiological Reviews·Jürgen Sandkühler

❮ Previous
Next ❯

Citations

Dec 19, 2014·Expert Opinion on Emerging Drugs·Eugene HsuSteven P Cohen
Apr 27, 2016·Indian Journal of Pharmacology·Veysel BaskınFatih İlkaya
Feb 11, 2015·Expert Opinion on Therapeutic Patents·Yoonji LeeSun Choi
Feb 11, 2014·The Journal of Allergy and Clinical Immunology·Mark A BirrellMaria G Belvisi
Oct 30, 2016·Basic & Clinical Pharmacology & Toxicology·Karl-Erik Andersson
Aug 1, 2015·Scientific Reports·Clive GentryStuart Bevan
Dec 8, 2017·Frontiers in Systems Neuroscience·Beverley Greenwood-Van Meerveld, Anthony C Johnson
May 28, 2019·Medical Sciences : Open Access Journal·Karl-Erik Andersson
Jan 3, 2014·Physiological Reviews·Emmanuel BourinetGerald W Zamponi
Jun 19, 2015·Current Opinion in Anaesthesiology·David S ChangSteven P Cohen
Mar 15, 2015·American Journal of Physiology. Gastrointestinal and Liver Physiology·Beverley Greenwood-Van MeerveldAnthony C Johnson
Oct 28, 2019·Neuropharmacology·Elizete Maria Rita PereiraMarcus Vinicius Gomez
Dec 31, 2017·Gastroenterology·Lin ChangJohn W Wiley

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.